echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Chemicals Industry > International Chemical > Phase 2 2022 - ExxonMobil acquires 49.9% of Biojet

    Phase 2 2022 - ExxonMobil acquires 49.9% of Biojet

    • Last Update: 2022-11-12
    • Source: Internet
    • Author: User
    Tags

    per

    phase

    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    ExxonMobil acquires a 49.
    9% stake in Biojet

    On January 11, ExxonMobil announced that it had agreed to acquire a 49.
    9 percent stake in Norwegian biofuels company Biojet, for an undisclosed
    amount.

    ExxonMobil said Biojet plans to convert forestry and wood-wood construction waste into low-emission biofuels and biofuel assemblies
    .
    Biojet plans to develop up to five production facilities, with commercial production
    expected to begin in 2025 at a plant to be built in Follum, Norway.
    Based on the potential capacity of these five facilities, ExxonMobil can purchase up to 3 million barrels of biofuel products
    per year.



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.